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Abstract
Purpose The purpose of this study was to compare the in-
hospital costs associated with the tissue-sparing supercapsular
percutaneously-assisted total hip (SuperPath) and traditional
Lateral surgical techniques for total hip replacement (THR).
Methods Between April 2013 and January 2014, in-hospital
costs were reviewed for all THRs performed using the
SuperPath technique by a single surgeon and all THRs per-
formed using the Lateral technique by another surgeon at the
same institution.
Results Overall, costs were 28.4 % higher in the Lateral
group. This was largely attributable to increased costs associ-
ated with transfusion (+92.5 %), patient rooms (+60.4 %),
patient food (+62.8 %), narcotics (+42.5 %), physical therapy
(+52.5 %), occupational therapy (+88.6 %), and social work
(+92.9 %). The only costs noticeably increased for SuperPath
were for imaging (+105.9 %), and this was because the
SuperPath surgeon performed intraoperative radiographs on
all patients while the Lateral surgeon did not.
Conclusions The use of the SuperPath technique resulted in
in-hospital cost reductions of over 28 %, suggesting that this
tissue-sparing surgical technique can be cost-effective primar-
ily by facilitating early mobilisation and patient discharge
even during a surgeon’s initial experience with the approach.
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Introduction
The economic burden of osteoarthritis (OA) continues to grow
as rising life-expectancy and obesity rates contribute to in-
creased incidence of the condition. In 2008, 13.4 million pa-
tients in the United States aged 65 years or older incurred
some expense due to treatment of OA resulting in health care
expenditures of $24.8 billion [1]. Total hip replacement (THR)
is one of the most common treatments of OA in the hip joint,
with annual volumes expected to reach 572,000 THRs in the
United States alone by 2030 [2]. As a result, THR represents
an excellent target for reducing the overall economic burden
of OA.
One aspect of THR with the potential to reduce costs is the
surgical technique. The supercapsular percutaneously-assisted
total hip (SuperPath®, MicroPort Orthopedics, Arlington, TN,
USA) surgical technique is a tissue-sparing approach that pre-
serves the external rotators and does not require the cutting of
any muscles or tendons to access the capsule [3]. Recently
published multicentre results for this technique showed sub-
stantial reductions in length of stay, 30-day readmission rates,
and transfusion rates compared to the national average in the
United States [4]. That study also provided examples of post-
discharge cost savings associated with the reduction of these
key variables. This is significant as post-discharge costs have
been shown to account for nearly 40 % of a THR episode of
care [5].
While potential post-discharge savings have been shown,
the in-hospital cost benefits associated with this technique
have yet to be examined. The primary objective of this study
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was to compare the in-hospital costs associated with the
SuperPath and standard Lateral surgical techniques. The stan-
dard Lateral, or Hardinge, technique was first described in
1982 [6], and has been used in approximately 40 % of THRs
captured in the National Joint Registry of England,Wales, and
Northern Ireland since 2008 [7]. It is anticipated that in-
hospital costs will be reduced for the SuperPath technique
when compared to the traditional Lateral due to the minimi-
zation of soft-tissue damage and ability of patients to ambulate
faster.
Methods
In-hospital costs were reviewed for all SuperPath THRs per-
formed by a single surgeon and all standard Lateral THRs
performed by another surgeon at the same institution between
April 2013 and January 2014. April 2013 was selected as the
start date because this is when the SuperPath surgeon per-
formed his first THR using the technique. The total costs, both
direct and indirect, minus the cost of implants were considered
in the analysis. Direct costs were defined as those attributed to
providing direct patient care including salaries, supplies, and
equipment amortisation. Indirect costs were defined as over-
head allocations based on a percentage of the activity in the
functional centre.
All aspects of cost associated with an in-hospital episode of
care were considered including secondary items like patient
food services. An episode of care was defined as beginning at
the time of admission prior to the THR procedure and ending
at the time of discharge from the hospital. Cost comparisons
were presented as the percent difference between the two
groups to protect proprietary hospital costing information.
Cost per patient values were used instead of total costs to
account for the different patient numbers in each group.
SuperPath technique overview
The SuperPath technique was performed as described by
Chow et al. [3] The patient was positioned in the lateral posi-
tion with the hip in 45° of flexion and 10–15° of internal
rotation. A 6- to 8-cm incision initiated at the greater trochan-
ter in line with the femoral axis, to the level of the gluteal
fascia was made. The gluteal fascia was incised and the glu-
teus maximus was split in line with the fibres. The interval
between the between the gluteus medius and minimus was
identified. A blunt holeman was placed between the capsule
and the minimus, followed by another blunt holeman between
the capsule and the piriformis. The sciatic nerve remained
protected by the intact short external rotators. The capsule
was incised in line with the incision from the base of the
greater trochanter to approximately 1 cm proximal to the ac-
etabular rim. The capsule was elevated as a flap for 1 cm
anterior and posterior to improve visualisation and the blunt
holemans were placed intracapsular. The femur was reamed
and broached without dislocation and with the femoral head
intact to minimise the potential for femoral neck fracture and
ensure restoration of the normal anatomic femoral version.
Starting in the anterior portion of the piriformis fossa, the entry
reamer was used to open the canal and a canal feeler was used
to ensure the location. A calcar punch was used to open the
femoral neck and head to allow passage of the broaches. Con-
secutive broaches were used until the broach was stable at a
level relative to the greater trochanter as predetermined via
templating. The superior aspect of the broach then served as
a cutting template and the head was extracted. A bone hook in
the implant and neutral rotation aided in anterior displacement
of the femur as a trial cup was placed into the acetabulum. A
portal placement guide allowed for the placement of a reaming
cannula just posterior to the trochanter in line with the planned
acetabular placement. The cannula was kept close to the femur
to ensure that it was well away from the sciatic nerve. Reamer
baskets were placed through the small incision and the small
hex reaming shaft was passed through the cannula, allowing
reaming with preservation of the short external rotators. The
definitive cup and polyethylene liner were placed in a similar
fashion with the option for alignment guides as desired. A trial
head and neck were placed and, using a blunt trochar to push
the femur with an assistant abducting or adducting the leg and
rotating the femur as directed, the neck was reduced into the
femoral head. The femur was assessed for stability and defin-
itive components were selected. The trial components were
separated and removed. The definitive femoral head was po-
sitioned and then a monoblock or modular femoral stem were
placed and the reduction manoeuvre was repeated. The cap-
sule was closed with a suture as was the gluteal fascia and
skin.
Lateral technique overview
The direct lateral approach was a slight modification of that
initially described by Hardinge [6]. Patients were positioned
in the lateral position and an incision approximately 10–15 cm
in length was centered over the greater trochanter. The gluteal
fascia and iliotibial band were incised in line with the skin
incision and a large retractor positioned. Cautery was used
to elevate the inferior 50 % of the gluteus medius tendon off
of the greater trochanter, leaving a cuff of tendon to allow a
suture repair of the tendon at closure. Distally, the incision
passed down to bone through the vastus lateralis in line with
the fibers. Proximally, the gluteus medius was split in line with
the fibres to the level of the acetabulum. The gluteus minimus
and capsule were split as a single layer in line with the medius.
The ligament of bigelow was released to facilitate dislocation
and determine the level of femoral neck osteotomy. Disloca-
tion was achieved by full adduction and external rotation. At
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closure, the capsule andminimus were closedwith a figure-of-
eight vicryl suture. The gluteus medius was repaired in a sim-
ilar fashion. Interrupted figure-of-eight vircyl was used to
close the iliotibial band, followed by interrupted suture and
staples for the skin layer.
Results
There were 49 SuperPath and 50 Lateral THRs performed
during the selected time period. Table 1 shows the patient
demographics for each group. The mean length of stay was
2.1 days (range, 1-4 days) for the SuperPath group and
5.1 days (range, 2–26) for the Lateral group. The mean total
in-hospital cost per patient in the Lateral group was 28.4 %
higher than that for the SuperPath group. Table 2 shows a
breakdown of in-hospital cost categories and which technique
had higher costs for each. Imaging costs were those associated
with obtaining and interpreting any imaging (e.g. radiographs,
ultrasound, computed tomography) performed during the ep-
isode of care. Narcotics costs included those associated with
the costs of the drugs, distribution and monitoring, pharmacy
labour, and intravenous admixture. Laboratory testing costs
included any related to laboratory testing (e.g. microbiology,
routine chemistry, routine haematology, pathology) performed
during the episode of care.
Discussion
The in-hospital costs for the SuperPath and standard Lateral
approaches were compared to determine if use of a tissue-
sparing surgical technique resulted in any in-hospital cost ben-
efits. It was anticipated that costs would be reduced for
SuperPath patients, as the technique has several features that
allow for early patient mobilisation and in turn reduced length
of stay. SuperPath utilises the interval between the piriformis
and the gluteus medius to access the hip capsule superiorly
without requiring the cutting of muscles or tendons, which
preserves the natural structures that resist dislocation. Posi-
tioning of the patient and femoral access are similar to that
used when placing an intramedullary rod, and the femur is
broached with the femoral head intact to theoretically reduce
the risk of periprosthetic fracture during preparation. In con-
trast, the Lateral approach requires the dissection of a signif-
icant portion of the gluteus medius, and often the minimus, as
well as splitting of the iliotibial band. This muscular dissection
likely leads to increased postoperative pain requiring more
narcotics usage, decreased postoperative abductor strength,
and reduced overall function and mobility that may all con-
tribute to increased in-hospital costs.
The results confirmed what was expected and showed that
mean total costs per patient were 28.4 % higher in the Lateral
group. The Lateral group also had higher costs in nearly all
individual cost categories, with imaging costs being the major
exception. Mean imaging costs were 105.9 % higher in the
SuperPath group. This was largely attributable to radiograph
costs, which were 198.8 % higher for SuperPath. Although
not required by the technique, the SuperPath surgeon collected
radiographs on all patients as a precaution because he was
performing these procedures during his learning curve with
the technique. The Lateral surgeon did not routinely collect
radiographs and therefore had substantially less cost associat-
ed with this activity. Many surgeons consider intraoperative
radiographs to be standard of care. If the costs of routine
radiographs were added to the Lateral group, then the mean
overall costs per patient would increase to 29.7 % higher for
the Lateral group.
The Lateral group had at least 42 % higher costs associated
with patient rooms, patient food, physical therapy, narcotics,
transfusions, occupational therapy, and social work. Several of
these differences were attributable to the decreased length of
stay observed in the SuperPath group. The average length of
stay for the Lateral group (5.1 days) was over twice that of the
SuperPath group (2.1 days), so it is not surprising that the
costs associated with patient rooms (Lateral +60.4 %) and
food services (Lateral +62.8 %) were over double for the
Table 1 Patient demographics for the SuperPath and Lateral groups
SuperPath Lateral
No. of patients 49 50
Male (%)/female (%) 38 %/62 % 34 %/66 %
Mean age (years) 68.1 73.1
Mean BMI 29.4 30.1
Table 2 In-hospital cost categories and comparison for the two groups
Cost Category Group with higher costs
(% Higher)
Overall Lateral +28.4 %
Admissions SuperPath +1.9 %
Operating room SuperPath +0.1 %
Post-anaesthesia care unit SuperPath +13.5 %
Transfusions Lateral +92.5 %
Imaging SuperPath +105.9 %
Narcotics Lateral +42.5 %
Laboratory testing Lateral +17.0 %
Patient room Lateral +60.4 %
Patient food Lateral +62.8 %
Physical therapy Lateral +52.5 %
Occupational therapy Lateral +88.6 %
Social work Lateral +92.9 %
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Lateral group. Additionally, physical therapy costs were
52.5 % higher in the Lateral group because, in general, phys-
ical therapists made daily visits to patients during their hospi-
tal stay. The finding of reduced length of stay agrees with the
previously cited multicentre study that found the length of stay
for SuperPath patients to be almost exactly half the national
average in the United States (1.6 vs. 3.3 days) [4].
Other cost differences, such as for transfusions, were not
directly attributable to reduced length of stay. Transfusion
costs were 92.5 % higher in the Lateral group. The institution
had a routine anticoagulation protocol in place for all patients
when the included THRs were performed. Under this proto-
col, patients with significant stroke risk (e.g. atrial fibrillation,
stents) received tranexamic acid prior to surgery. There was
also a routine transfusion protocol that covered all included
THRs on the unit. Due to the identical anticoagulation and
transfusion protocols, the reduction in transfusions can be at
least partly attributed to the tissue-sparing nature of the
SuperPath procedure. This finding also agrees with the de-
scribed recent multicentre study showing a substantial reduc-
tion in transfusion rates for this technique when compared to
the national average in the United States [4]. Transfusions
have been associated with increased complications, such as
infections [8, 9]. This suggests that the reduction in transfu-
sions seen in the SuperPath group may have the potential to
decrease not only in-hospital costs but also those associated
with treating complications related to transfusions.
Narcotics costs were 42.5 % higher in the Lateral group.
This included the costs of the narcotics themselves (41.6 %
higher), distribution and monitoring (35.9 % higher), and in-
travenous admixture (35.6 %). While some of the cost reduc-
tion in the SuperPath group can be attributed to the reduced
length of stay, the tissue-sparing nature of the technique likely
also plays a role. The SuperPath technique is intramuscular,
requiring no muscle release, preserves the external rotators,
and minimises stretching of the gluteus medius. All these fac-
tors may play a role in reduced postoperative pain and, in turn,
narcotics usage. Initial reports with this technique support this
suggestion by showing patient pain was well controlled using
only oral medications [3]. The SuperPath technique is a hybrid
of the superior capsular (SuperCap®, MicroPort Orthopedics)
and percutaneously-assisted total hip (PATH®, MicroPort Or-
thopedics) approaches [10, 11]. Reports for both of these tech-
niques agree with that previously reported for SuperPath and
show patient pain can be controlledwith only oral medications
[12, 13].
The average per patient cost associated with in-hospital
occupational therapy was 88.6 % higher in the Lateral group.
Occupational therapists generally spend time with patients
instructing them on various activities of daily living (e.g. sit-
ting, putting on clothes, performing simple household tasks)
to prepare them for their discharge from the hospital. In our
unit, the occupational therapists are requested to review
patients when the physician or physiotherapists feel their mo-
bility is sufficiently limited to warrant a consult to avoid de-
lays in a safe discharge home. The large reduction in these
costs is possibly associated with improved early ambulation
and function in the SuperPath group and the reduced number
of visits required due to the decreased length of stay.
Social work costs were 92.9 % higher for the Lateral
group. Social workers facilitate arrangements for post-
discharge care and help patients with practical aspects
of THR, such as labour laws for requesting time off
from work. One factor likely associated with the higher
social work costs is that four (8.0 %) Lateral patients
were sent to short-term rehabilitation facilities, while no
SuperPath patients were. Arrangements to send patients
to these facilities are managed by the social work group
at our institution.
The mean per patient costs associated with admissions,
operating room, and the post-anesthesia care unit were similar
for the two groups. This suggests that use of the SuperPath
technique does not result in increased operating room usage or
patient time in the post-anesthesia care unit when compared to
the standard Lateral approach. Further, the SuperPath tech-
nique does not require the use of specialty surgical tables or
other equipment, and as such does not require any additional
capital expenses from the hospital. Another potential benefit
of the technique is that it can be performed with only a single
assistant, which could result in increased operating room
efficiencies.
Limitations
The study is not a randomised comparison of patients
implanted by the same surgeon. Efforts were made to
minimise the bias introduced from this limitation by
selecting patients implanted during the same time period
at the same institution. This ensured patients were treated
with identical anticoagulation and transfusion protocols,
while also receiving pre- and postoperative care at the
same facilities. Patients in the Lateral group were
five years older on average and this has the potential to
play a role in increased hospital length of stay. Another
limitation was the different levels of experience the
implanting surgeons had with the two surgical techniques.
The SuperPath surgeon was completing his first 49 THRs
using the technique, while the other surgeon had signifi-
cant experience with the Lateral technique. Future work is
needed to examine if there any longer term benefits for
SuperPath, as a recent report for the direct anterior ap-
proach showed similar outcomes when compared to the
lateral at midterm follow-up [14]. Future studies of interest
could also determine if there are benefits for select patient
populations (e.g. obese patients) as have been examined
recently for other surgical techniques [15].
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Conclusions
In conclusion, the use of the SuperPath surgical technique
resulted in in-hospital cost reductions of over 28 % when
compared to the standard Lateral performed at the same insti-
tution. Pre-operative and operative costs were similar between
the two groups, with the majority of savings occurring due to
reductions in length of stay, narcotics, transfusions, physical
therapy, occupational therapy, and social work costs. These
outcomes suggest this tissue-sparing surgical technique can
be cost effective primarily by facilitating early mobilisation
and patient discharge even during a surgeon’s initial experi-
ence with the approach.
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